The Phase II trial, originally expected to run for 24 months is expected to open a larger significant opportunity for the Company as the trial progresses.
Ann: CardieX Announces Expansion of Bayer Pharma Trial Contract, page-3
Add CDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
-0.010(6.67%) |
Mkt cap ! $17.65M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 17.5¢ | 13.5¢ | $186.0K | 1.196M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 53157 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 14000 | 1 |
View Market Depth
| Last trade - 13.57pm 15/11/2024 (20 minute delay) ? |
| CDX (ASX) Chart |
